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ABSTRACT  Expression  of ornithine  transcarbamylase  (OTC), a nuclear-coded  mitochondrial 
enzyme,  was programmed  in  HeLa cells  by the  use of a strategy  of gene co-amplification. 
HeLa cells, ordinarily devoid of OTC activity, were transfected with a plasmid containing viral 
regulatory  elements  joined  with  two  cDNA  sequences,  one  encoding  the  human  OTC 
precursor and a second encoding a mutant mouse dihydrofolate reductase. After transfection 
and selection  in  increasing concentrations  of methotrexate,  several  hundred copies  per cell 
of  the  sequence  encoding  OTC  were  detected  by  blot  analysis.  Immunoprecipitation  of 
extracts  of radiolabeled  cells  with  anti-OTC  antiserum  revealed  newly  synthesized  mature 
OTC subunits.  Furthermore, OTC enzymatic activity  in cell extracts  was comparable to that 
of control  human  liver, and  mitochondrial  localization  of OTC was demonstrated  by immu- 
nofluorescence.  When  we  incubated  transfected  HeLa  cells  with  dinitrophenol,  a  known 
inhibitor of mitochondrial  import, the only form of newly synthesized OTC detected was the 
precursor. We estimated the rate of import of precursor by performing an inhibitor-free chase; 
precursor was converted to mature subunit with a half-life of less than two minutes. When a 
HeLa transformant was incubated  with the arginine analogue canavanine,  the major form of 
newly synthesized OTC detected was a species migrating slightly more slowly than the normal 
precursor;  little  mature-sized  subunit  was recovered.  This  indicates  that substitution  of the 
analogue for arginine in the OTC precursor interferes with mitochondrial  import and process- 
ing. Thus, arginine residues  in the OTC precursor--most likely the four residues  contained  in 
its NH2-terminal  leader sequence--probably  play an important role in  mitochondrial  import 
and/or processing. 
The vast majority of mammalian mitochondrial proteins are 
encoded in the nucleus, translated as larger precursors on free 
cytoplasmic polyribosomes, and posttranslationally imported 
by mitochondria. Import requires specific recognition by the 
mitochondria, translocation across one or both mitochondrial 
membranes, and proteolytic removal of NHE-terminal leader 
sequences to produce the mature protein. A number of  details 
concerning these steps have been elucidated during the past 
few years:  recognition involves outer membrane receptors; 
translocation across the inner membrane requires an intact 
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electrochemical  gradient; and proteolytic  cleavage is catalyzed 
by a divalent cation-dependent matrix protease (for review 
see reference 1). However, a large number of biochemical and 
cell physiological questions remain unanswered.  Precursors 
incubated with isolated mitochondria are imported, whereas 
the corresponding mature proteins fail either to be taken up 
or to interfere with uptake of  the precursors (1). This indicates 
that leader sequences are required for recognition. How do 
these sequences function? Do they contain specific "address" 
information? 
1515 One approach to answering these questions is to analyze 
the structure of the leader sequences. Recently we reported 
the  complete  amino  acid  sequence  of the  precursor  of a 
human  hepatic  mitochondrial  matrix  enzyme,  ornithine 
transcarbamylase (OTC) ~ (2).  We  compared the  leader  se- 
quence of OTC with the sequences of those leaders analyzed 
to date from precursors of mitochondrial enzymes from yeast 
(3-5),  Neurospora (6),  and  rat (7),  and  failed to  find  any 
shared  sequence.  However,  several features of amino  acid 
composition are shared: the leaders do not contain stretches 
of hydrophohic residues; they are devoid of acidic residues; 
and they contain an average number of basic residues when 
compared with eukaryotic proteins. In particular, the OTC 
leader  contains  four  arginine  residues  in  a  peptide  of 32 
residues. Because the overall amino acid composition of the 
leaders is basic, they are predicted to be positively charged 
(2). 
To define further the characteristics of mitochondrial im- 
port, we sought to establish a cultured cell system expressing 
OTC. Such a system had not been available because the intact 
liver is usually the only site of major OTC expression; cell 
lines derived from either hepatic tumors or normal liver are 
essentially devoid of enzyme activity. We previously achieved 
low levels of OTC activity in  HeLa cells  after transfection 
with a plasmid programming expression of the cloned cDNA 
(2). Here we describe high-level expression of OTC in HeLa 
cells, with enzyme activity similar to that of intact liver.  To 
achieve this, we used a strategy ofgene amplification proposed 
by Simonsen  et  al.  (8),  in  which  sequences  programming 
expression of the  OTC product were co-amplified with  se- 
quences programming expression of a  dominant,  selectable 
marker, a mutant dihydrofolate reductase (DHFR). 
MATERIALS  AND  METHODS 
Recombinant DNAs, DNA-mediated Gene Transfer, and 
DNA Hybridization Analysis:  We prepared  recombinant  DNAs  using 
previously described methods of  restriction endonuclease digestion, purification 
of DNA fragments, joining of DNA fragments, bacterial transformation,  and 
colony  screening  (2). Plasmid  DNA  was transferred  into  cultured  cells by 
calcium-phosphate  co-precipitation  (9,  10). Preparation  of high  molecular 
weight DNA, agarose gel electrophoresis, transfer of DNA, and hybridization 
with a nick-translated plasmid were performed as described elsewhere (l 1). 
Transfection and Selection:  HeLa  cells were grown in  minimal 
essential medium with Earle's salts (MEME) containing  10% fetal calf serum. 
Two different transfection protocols were carried out, each using the calcium 
phosphate-mediated  procedure  of Wigler et al. (10). In one,  HeLa cells were 
co-transfected with two plasmids, one encoding OTC and the other encoding 
the bacterial gene for neomycin resistance. Selection was carried out by addition 
of G418 (Geneticin, Gibco Laboratories, Grand Island, NY) to the medium at 
a  concentration  of 400  #g/ml  (12). In  the  second  experiment,  cells were 
transfected with a single plasmid that encodes both OTC and a mutant form 
of DHFR. Selection was carried out by addition  of 4 #g/ml folic acid and 0.2 
#M methotrexate  (added from a stock solution, 25 mg/ml, kindly supplied by 
Dr. Ferstenberg of Lederle Laboratories Div., American Cyanamid Co., Wayne, 
N  J) (8). After initial  selection, six transfectants  were grown in progressively 
higher concentrations of methotrexate added to the same medium (see Results). 
Inhibitors and Amino Acid Analogues:  In pulse-chase experi- 
ments, 4 mM dinitrophenol  (DNP) was added  to the medium one-half hour 
before the labeling period and was present during radiolabeling and washes in 
nonradiolabeled  medium,  but not during  the chase period (13). Rhodamine 
6G (R6G)  was used  as previously described  (2). Canavanine  incorporation 
studies were performed as follows. Cells grown to -70% confluence in 60-mm 
t Abbreviations used in this paper: DHFR, dihydrofolate reductase; 
DNP,  dinitrophenol; kb,  kilobase; MEME,  minimum essential me- 
dium  with  Earle's  salts;  OTC,  ornithine  transcarbamylase;  R6G, 
rhodamine 6G. 
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dishes were rinsed twice with phosphate-buffered  saline (PBS), then  2 ml of 
arginine and methionine-deficient  MEME (Select-Amine Kit, Gibeo  Labora- 
tories) was added. The cells were incubated at 37°C for I h, and canavanine (L- 
canavanine sulfate, Sigma Chemical Co., St. Louis, MO) was then added to the 
desired  concentration.  After  20  rain,  the  medium was replaced  with  fresh 
arglnine/methionine-deficient  medium containing  the same concentration  of 
canavanine and l0 #Ci/ml [~SS]methionine, and incubation was continued  for 
l h and followed by harvest of  the cells. L-Ethionine and p-fluoro-phenylalanine 
(Sigma Chemical Co.), amino acid analogues of  methionine and phenylalanine, 
respectively, were used similarly. Competition  with the corresponding natural 
amino acid was verified by parallel incubations in which total incorporation  of 
the labeled natural amino acid into TCA-precipitable products was measured 
in the presence and absence of the analogue. In all cases, incorporation  in the 
presence of analogue was <5% of that in its absence. 
Immunoprecipitation:  Procedures  for  radiolabeling  cultured  cells 
and for harvesting, immunoprecipitation,  and SDS PAGE have been described 
previously (13). 
Immunofluorescence:  Cells  were plated on round glass coverslips, 
cultured  for  24-48  h  in  complete  medium,  and  fixed by  the  use  of 3% 
paraformaldehyde  0.05% glutaraldehyde  in PBS (15  rain,  22°C). Fixed cells 
were permeahilized in cold methanol (-20*C,  30 s), quenched in PBS contain- 
ing 50 mM NH4CI, and incubated  in a  1:100 dilution  of either anti-OTC  or 
control  rabbit serum (30 rain,  22°C). After being extensively washed in PBS, 
coverslips were incubated in a 1:40 dilution of a fluoreseein-conjugated affinity 
purified  F(ab')2 goat anti-rabbit  IgG (Tago  lnc.,  Budingame,  CA) (30 rain, 
22*C). After coverslips were washed, they were mounted in Moviol and exam- 
ined under a Zeiss microscope equipped  with an epifluorescence illuminator. 
All  antibody  containing  preparations  were diluted  in  PBS containing  0.2% 
gelatin just before use, and centrifuged (2 rain,  12,000 g). 
For staining mitochondria  with R6G (14), cells were incubated for 30 min 
at 37"C in medium containing  R6G at a concentration  of 1 #g/ml.  After they 
were washed in PBS, coverslips were examined immediately (without fixation) 
under a Zeiss 40X water immersion lens. 
Enzyme Purification and Assay:  We prepared extracts of cultured 
cells by sonication in 0.5% Triton X-100, 10 mM HEPES pH 7.5, and l mM 2- 
mereaptoethanol.  Extracts of human liver were prepared by homogenization 
in  the  same  buffer,  After  30  rain  of incubation  at  0oc,  the  extracts  were 
centrifuged for  l0 min at  10,000 g and supernatants  were assayed for OTC 
enzymatic activity as described previously (15). 
RESULTS 
High-level Expression of OTC in HeLa Cells 
We wished to achieve high-level expression of the precursor 
of OTC through co-amplification of a sequence programming 
its expression with that of a  mutant methotrexate-resistant 
DHFR (8). The mutant DHFR has a greater Ki that does the 
normal enzyme for the folate antagonist, methotrexate, and 
therefore serves as a dominant selectahle marker, permitting 
growth oftransformants that express this sequence in concen- 
trations of methotrexate that kill nontransformed cells.  Ex- 
posure of methotrexate-resistant transformants to increasingly 
higher concentrations  of methotrexate permits  selection  of 
transformants that may contain several hundred copies of the 
sequences expressing the mutant DHFR (8). To increase the 
likelihood  that  OTC  sequences  would  be  included  in  the 
amplified unit, the sequences programming OTC expression 
were physically joined with those programming expression of 
the  mutant  DHFR  as  shown  in  Fig.  1.  Plasmid  pFR 400 
(kindly provided by C. Simonsen, Genentech Inc., San Fran- 
cisco, CA) contains a cDNA sequence encoding the mutant 
DHFR, joined upstream with the SV40 early promoter and 
enhancer sequence  and  downstream with  hepatitis  B  virus 
sequences encoding a polyadenylation signal.  The sequences 
that program expression of the mutant DHFR were inserted 
at  the  unique  Eco  RI  site  of pSV2OTC,  a  plasmid  that 
programs expression of cDNA for the OTC precursor from 
SV40  regulatory  elements  (2).  The  two  derived  plasmids, 
pODf  and  pOE)b, contained  head-to-tail  and  head-to-head 
orientations of the expression segments, respectively. p•iV4Ointron  "" /~-------~  and pA 
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hGURE  1  Construction of plasmids containing cDNA sequences 
encoding both the OTC precursor and a mutant DHFR joined with 
viral  regulatory sequences.  The  plasmid  pFR400  (8)  was  kindly 
supplied  by  Christian  Simonsen.  The  DNA  fragment  containing 
cDNA coding for a mutant DHFR is shown by the open bar, the 
direction of transcription by an arrow. The DHFR sequence is joined 
at its upstream terminus with SV40 sequences and at its downstream 
terminus with regulatory sequences from hepatitis  B virus, shown 
by dark bars. The Pvu H-Sal 1  fragment containing the DHFR cDNA 
and regulatory sequences  was purified and treated with  Klenow 
fragment  of Polymerase I to produce flush termini. The fragment 
was joined with plasmid pSV2OTC, containing  a human OTC cDNA 
sequence, shown by the open bar, and adjoining SV40 regulatory 
elements,  shown  by  dark  bars. pSV201-C was  prepared for the 
joining reaction by digestion with Eco RI, incubation with bacterial 
alkaline phosphatase, and treatment with Klenow fragment of Po- 
lymerase I. Blunt-ended joining allows two possible orientations of 
the cDNA sequences relative to each other. Recombinant plasmids 
with both orientations were identified and the plasmids were des- 
ignated  pOD~ (OTC-DHFR  head-to-tail) and  pODu  (OTC-DHFR 
head-to-head). Loss of Eco RI recognition sequences at the sites of 
joining is indicated by X marks. ORI, SV40 origin of replication; R/, 
Eco RI; gAP, bacterial alkaline phosphatase. 
The OTC-DHFR plasmids were introduced into HeLa cells 
by calcium phosphate co-precipitation. HeLa cells were cho- 
sen as the recipient because SV40 regulatory elements, used 
for expression of both  DHFR and  OTC eDNA sequences, 
have been shown to function efficiently in this cell line. 48 h 
after transfection,  selection  was  started  by  the  addition  of 
methotrexate to  the  culture  medium at a  concentration  of 
200 nM. After 12 d of growth in selective medium, transfor- 
mant clones were identified  in  equal  numbers  for the  two 
plasmids. 20 were analyzed for OTC enzymatic activity. Of 
these,  18 contained detectable activity; no activity was mea- 
sured  in  untransformed  HeLa cells.  The  six  transformants 
(three pODr, three 0OI%) with the greatest OTC activity were 
subjected to stepwise increases of methotrexate concentration, 
first to 10 then to 500 #M. 
Five transformants survived selection in  500  #M  metho- 
trexate and were maintained in this concentration of metho- 
trexate. The lines were designated OD cell lines because they 
contain  both  OTC  and  DHFR  sequences.  The  lines  were 
analyzed for the  presence of immunoprecipitable OTC, for 
OTC enzymatic activity, and for copy number and arrange- 
ment of OTC DNA sequences. The results of immunoprecip- 
itation of extracts of radiolabeled OD cell lines with anti-OTC 
antiserum are shown in Fig. 2. All five lines contained precip- 
itable product that co-migrated in SDS PAGE with the mature 
rat OTC subunit. The intensity of this band was significantly 
greater than  that  found  upon  analysis of a  similar extract 
from the  cell  line  D6,  a  stable  transformant  derived  after 
cotransfection  of HeLa  cells  with  two  separate  plasmids, 
pSV2Neo and pSV2OTC. (The D6 line contained the greatest 
amount of  OTC enzymatic activity of 30 stable G418-resistant 
co-transformants.) The OD lines also contained a much less 
intensely  labeled  immunoprecipitable  product  that  co-mi- 
grated  with  the  rat  OTC  precursor  (Fig.  2).  The  latter  is 
presumed to be newly synthesized precursor that has not been 
processed to the mature form. 
The results of assay of the OD cell lines for OTC enzymatic 
activity are shown in Table I along with the results obtained 
for  two  OTC-Neo  co-transformants,  untransformed  HeLa 
cells,  and control human liver. As mentioned above, HeLa 
cells contain  no detectable activity. The OTC-Neo cotrans- 
formant, D6, contains -5% of the activity found in liver. The 
OD  lines  (ODI,  OD2,  OD5)  have  activities  an  order  of 
magnitude greater than  that  of D6  and  comparable to  the 
activity  found  in  human  liver.  The  line  designated  OD5 
contained the greatest amount of activity, at the upper limit 
of the range of activity of human liver. 
OTC Sequences  in HeLa Cell Transformants 
To analyze the DNA sequences encoding OTC in the HeLa 
transformants,  high  molecular  weight  DNA  was  prepared 
from the lines initially during growth in 0.2 #M methotrexate 
FIGURE 2  OTC expression in 
stable  HeLa  cell  transform- 
ants.  Stable  HeLa  cell  trans- 
formants, derived either from 
transfection  with  pSV2OTC 
and  pSV2Neo  (D6) or  from 
transfection  with  pODf  and 
pODb (OD  1, 2, 3, 5, 6), were 
grown  to  near confluence in 
60-mm  dishes  in  MEME  + 
G418  (line  D6)  or  MEME + 
folate + 500 #M methotrexate 
(OD transformants  1, 2,  3, 5, 
6). The growth medium was replaced by labeling medium and the 
cells were incubated for 1 h with [3SS]methionine. The monolayers 
were washed and  harvested  by detergent lysis, and the extracts 
were immunoprecipitated with anti-OTC antiserum. The products 
were electrophoresed through an SDS-polyacrylamide gel, and the 
gel was fluorographed. Portions of the same fluorogram are shown; 
exposure times were the same for all lanes, pOTC, OTC precursor; 
OTC, mature OTC subunit. 
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OTC Enzymatic Activity in HeLa Transformants and Human 
Liver 
U*/mg protein 
HeLa  <0.2 
Neo co-transformants 
AI  0.8 
D6  1.4 
Mtx  R  DHFR co-transformants 
OD-1  29.7 
OD-2  25.3 
OD-3  12.3 
OD-5  38.3 
OD-6  9.2 
Human liver  30 (20-40 range) 
Cell-free extracts  of HeLa cell  transformants  (one or two confluent 10-cm 
dishes)  and  liver tissue  were prepared  as in  Materials  and  Methods and 
assayed for OTC enzymatic activity by the method of Kalousek et al. (15). 
Activity  is expressed  as micromoles of citrulline  produced  per  hour  per 
milligram  extract protein. 
* U, micromoles citrulline per hour. 
and again after selection in 500 #M methotrexate. DNA was 
digested with Bam HI, electrophoresed through a 0.8% aga- 
rose gel, transferred to nitrocellulose by the method of South- 
ern (16), and probed with a nick-translated plasmid, pHO731, 
containing  a  nearly  full-length  OTC  cDNA  joined  with 
pBR322. Two Bam HI sites are present in the input plasmids 
pODf and pOl~--one in an  SV40 regulatory segment (see 
Fig.  1) and the other in the OTC leader coding sequence (site 
not shown in Fig.  1). Cleavage of the plasmid DNA at these 
sites  produces a  fragment of 2.2  kilobases (kb),  containing 
nearly all of the OTC sequences, and a fragment of 4.0 kb, 
containing the DHFR sequences, pBR322 sequences, and the 
5'  terminal OTC sequences (40 base pairs).  Analysis of all 
five OD cell lines, shown in Fig. 3, revealed a 2.2-kb hybrid- 
izing fragment that probably corresponds to the OTC-bearing 
fragment of the input plasmids. The intensity of this band in 
tracks containing DNA from cells grown in 0.2 gM metho- 
trexate is greater than that of the two high molecular weight 
bands in the nontransfected HeLa track characteristic of the 
normal X chromosome OTC locus (11), indicating the pres- 
ence of multiple OTC sequences even at the initial metho- 
trexate concentration used for selection. After selection in 500 
gM methotrexate, the intensity of hybridization of the 2.2-kb 
fragment from OD 1, OD2, and OD5 is about two orders of 
magnitude greater than  observed at  0.2  ~M  methotrexate, 
which suggests a corresponding increase in copy number of 
OTC sequences in these lines.  The source of additional hy- 
bridizing bands in the OD lines is unclear, although the single 
additional band observed for the OD5 line corresponds pre- 
cisely to the 4.0-kb Bam HI fragment of the pOD plasmids 
and suggests that, in this line, the multiple copies of plasmid 
DNA have assumed a simple head-to-tail configuration. 
Analysis of DNA from the OTC-Neo transformant D6 also 
reveals a 2.2-kb hybridizing fragment, probably corresponding 
to the OTC-bearing Bam HI fragment present in the input 
plasmid pSV2OTC (see Fig.  1). The intensity of hybridization 
of this fragment is  well  above single  copy (compare HeLa 
lane in  Fig.  3) and  is similar to that  of OD lines 3 and  6 
selected in 500 #M methotrexate, yet, curiously, OTC enzy- 
matic activity in D6 is an order of magnitude less. Both the 
D6 and OD5 lines were subjected to karyotype  analysis, which 
detected  a  hypotetraploid  chromosome  complement  but 
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FIGURE 3  Hybridization  analysis of DNA from HeLa cell transform- 
ants.  High  molecular weight  DNA  was  isolated  from  the  OTC- 
DHFR transformants (OD 1, 2, 3, 5, 6), both after initial selection in 
0.2 ~M methotrexate  and after subsequent amplification in 500/~M 
methotrexate. DNA was also prepared from  untransfected  HeLa 
cells and from the OTC-Neo cotransformant  D6. DNA was digested 
with BamHI,  separated by electrophoresis in a 0.8% agarose gel, 
and blotted to nitrocellulose. The filter was hybridized with a nick- 
translated  plasmid,  pHO731, which  contains  a nearly full-length 
human OTC cDNA. The 2.2-kb  hybridizing fragments correspond 
in size to a Bam fragment containing almost all of the OTC cDNA 
sequence present in plasmids pODf and pODb, and in pSV2OTC. 
See Results for details concerning hybridization pattern. 
failed to  detect either a  homogeneously staining  region or 
double minute chromosomes. 
Localization of OTC  in OD5  Cells 
To demonstrate directly the presence of OTC in the mito- 
chondria of a  transformant, cells  from the  OD5  line were 
fixed, permeabilized, and incubated with monospecific rabbit 
anti-OTC antiserum, then fluorescein isothiocyanate-conju- 
gated goat anti-rabbit IgG antiserum was added. Fig. 4 shows 
the results of this study. A threadlike pattern of fluorescence 
is visible,  characteristic of the morphologic pattern of mito- 
chondria in HeLa cells (see below).  Virtually all of the cells 
in the population were positive for OTC expression by this 
assay. No fluorescent pattern was detected when the procedure 
was  carried out  either with  nontransformed HeLa ceils  or 
with normal rabbit serum instead of anti-OTC antiserum (not 
shown). However, when either HeLa cells or OD5 cells were 
incubated with R6G, a fluorescent dye that binds selectively 
to mitochondrial membranes (14), we observed a fluorescent 
pattern identical to that  obtained for OD5  cells  incubated 
with anti-OTC antiserum (not shown). 
Rate of Import of OTC  by Mitochondria 
The establishment of cultured cell lines that express OTC 
affords the  possibility of estimating the  rate  of import by 
mitochondria of cytoplasmically synthesized OTC precursor. 
Such an analysis relies on proteolytic  cleavage of  the precursor 
polypeptide by one or more proteases localized to the matrix 
space (17) as an indication of entry of the OTC subunit. To 
permit this analysis of import,  we synthesized radiolabeled 
precursor by metabolically labeling the cells with [35S]methi- 
onine in  the  presence of DNP,  an  uncoupler of oxidative 
phosphorylation, which has been demonstrated to inhibit the 
import of the OTC precursor (17). After labeling was done in 
the presence of DNP, [35S]methionine and DNP were washed 
from the cells and incubation was carded out in nonlabeled FIGURE  4  Localization of OTC in OD5 cells by indirect immunofluorescence. OD5 cells were grown on glass coverslips,  fixed, 
permeabilized in methanol, and stained for OTC by the use of a rabbit anti-rat OTC antiserum. In some cases, the fluorescent 
organelles correspond to structures seen by phase-contrast microscopy (right). See text for details, x  360. 
medium for various times. The results of immunoprecipita- 
tion of the extracts of the harvested cells are shown in Fig.  5. 
In the  absence  of DNP,  only the  mature  OTC  subunit  is 
detected,  whereas  in  its  presence only the  precursor is de- 
tected. Within 2  min of release from DNP inhibition,  more 
than half of the radiolabeled precursor has been converted to 
the mature subunit. By 6 min nearly all precipitable material 
corresponds to the mature subunit. Thus, the tt/2 for import 
and cleavage in this system is estimated to be <2 min. 
Effect of Canavanine  on Import of OTC in 
OD5 Cells 
The establishment of cultured cells that express and import 
the OTC precursor permits a direct analysis of the amino acid 
residues required for import by substituting amino acid ana- 
logues in  the OTC precursor for the  corresponding natural 
amino acids.  We have previously noted that the  leader se- 
quences of those mitochondrial precursors analyzed to date 
share an  overall basic composition.  In the  OTC leader se- 
quence below, all four basic residues are arginines (2): 
FIGURE  5  Time course of mitochondrial import and processing of 
OTC.  Cultures  of  the  stable  transformant  (D6)  were  grown  to 
confluence  in  60-mm  dishes  in  MEME. The  monolayers  were 
washed, incubated with 4 mM DNP, and labeled with [35S]methi- 
onine for 1 h. Then the labeling medium was removed and replaced 
with MEME without DNP. At each indicated time, one plate of cells 
was harvested  by detergent lysis, and the labeled OTC  products 
were recovered by immunoprecipitation. The products of immu- 
noprecipitation were separated by polyacrylamide gel electropho- 
resis and fluorographed. The first  lane (-DNP)  shows the product 
obtained when both the labeling and the chase were performed in 
the absence of DNP. 
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Given  the  possibility  that  these  arginine  residues  play  an 
essential role in mitochondrial import, the effect of substitu- 
tion of these residues, as well as of eight arginine residues in 
the mature portion of the  precursor, by the analogue cana- 
vanine, was examined. 
The results of such an experiment are shown in Fig. 6. OD5 
cells were incubated for 20 min with arginine-free medium 
supplemented  with  2  mM  canavanine.  The  medium  was 
replaced with  fresh canavanine-supplemented, arginine-free 
medium containing [35S]methionine,  and incubation was car- 
fled out for l  h and followed by harvest and immunoprecip- 
itation with anti-OTC antiserum. A control radiolabeled cul- 
ture incubated in arginine-containing medium contained only 
the mature OTC subunit (Fig.  6A, lane I). When the mito- 
FIGURE  6  Effect of canavanine on mitochondrial import and proc- 
essing of OTC. The OTC-DHFR cell transformant OD5 was grown 
to near confluence in 60-mm dishes  in MEME +  folate +  500 ~.M 
methotrexate. Cells were radiolabeled with [3SS]methionine in the 
absence or presence of canavanine and/or R6G. Monolayers were 
washed, harvested by detergent lysis, the OTC products immuno- 
precipitated and electrophoresed, and the gel fluorographed. Por- 
tions of the same fluorogram are shown. (A) Extract of cells radio- 
labeled under control conditions (lane  I); in the presence of 1 #g/ 
ml R6G (lane 2); in 2 mM t-canavanine (lane 3); in 1 /zg/ml R6G and 
2 mM canavanine (lane 4); in 2 mM canavanine and 0.6 mM arginine 
(lane 5). (B) Extracts of cells  radiolabeled in the presence of 0 mM 
(lane  1), 0.2 mM (lane 2), 2  mM (lane 3), and  10 mM canavanine 
(lane 4). 
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culture, only the OTC precursor was observed (Fig. 6A, lane 
2).  In the  presence of 2  mM  canavanine,  two precipitable 
products were detected (Fig. 6A, lane 3), a major one migrat- 
ing slightly more slowly than the  normal precursor,  and a 
minor one migrating slightly more slowly than the mature 
subunit from untreated cells.  The altered mobilities of these 
OTC products show that canavanine has been incorporated 
into them. The major product appears to be an altered form 
of the OTC precursor. This is supported by the observation 
that when R6G is added to the canavanine-containing me- 
dium only this OTC product is detected (Fig.  6A,  lane 4). 
The minor OTC product, which disappears in the presence 
of R6G, is a product of proteolytic processing by the mito- 
chondria. Whether this cleavage product is an altered mature 
form of OTC or an intermediate form resembling that previ- 
ously  reported  by our group  and  others  cannot  be distin- 
guished. 
To demonstrate  further  that  canavanine  is  incorporated 
into the OTC precursor, we performed two additional exper- 
iments. In one, arginine was added to the culture medium at 
the same time as canavanine (Fig.  6A, lane 5). Under these 
conditions only the mature form of OTC was detected, which 
indicates successful competition by arginine for incorporation 
into the OTC precursor. In the second, the effect of adding 
varying concentrations of canavanine was determined. At a 
canavanine concentration of 0.2 mM (Fig.  6B, lane 2), four 
products were detected. We propose that, at 0.2 mM, cana- 
vanine competes only partially with endogenous arginine for 
incorporation into the precursor. As a result, the precursor is 
canavanine substituted to a variable extent. The least substi- 
tuted  precursor is  converted to  mature  OTC,  whereas the 
most completely substituted appears as an altered precursor. 
The nature of the two forms that are intermediate in mobility 
is unclear. In agreement with this interpretation, the normal- 
sized precursor and mature products are reduced at 2  mM 
canavanine concentration and are totally absent at  l0 mM 
concentration (Fig. 6B, lanes 3 and 4). 
The effect ofcanavanine upon import of  the OTC precursor 
was not reversed by the subsequent removal of the analogue 
from  the  culture  medium  and  replacement with  arginine. 
When cells were radiolabeled in the presence of canavanine, 
and  a  cold chase in  arginine-containing medium was then 
performed, no new products were observed and the half-life 
of the  observed products was estimated to  be 40  min.  In 
another experiment designed to test whether the mitochon- 
drial import system is functional after incubation in canavan- 
ine, cells were first incubated with canavanine and were then 
radiolabeled in medium in which canavanine was replaced by 
arginine. At all points examined, mature OTC was the only 
product detected (data not shown). 
DISCUSSION 
High-level Expression of the OTC Precursor in 
HeLa Cells 
The results presented above have described the high-level 
expression of a mammalian mitochondrial precursor in cul- 
tured HeLa cells. This was achieved through co-amplification 
of a sequence that programmed expression of the precursor 
with  a  sequence  that  programmed  a  dominant  selectable 
marker. Physical linkage of the two sequences in the input 
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plasmid probably contributed to the uniformly observed am- 
plification of  the nonselected sequences. The derived cell lines 
contained several hundred copies of these sequences, which 
had been joined in the input plasmid with a  promoter and 
enhancer sequence that function efficiently in the HeLa cell 
recipient. Both the high template copy number and an effi- 
cient promoter led to high-level expression of OTC products 
in cells that do not normally express OTC. 
The OTC precursor synthesized in the derived OD cell lines 
is  efficiently and  faithfully  imported  by  mitochondria,  as 
supported by three lines of experimental evidence: immuno- 
precipitation  of cell  extracts reveals almost exclusively the 
mature form of the OTC subunit; cell extracts contain OTC 
enzymatic activity, which has been observed only with the 
assembled trimer of mature subunits; and indirect immuno- 
fluorescent analysis of the fixed cells with  OTC antiserum 
reveals a pattern of  mitochondrial fluorescence. As a reflection 
of the efficiency of import, only relatively small amounts of 
OTC precursor were detected in immunoprecipitates, and no 
fluorescence was detected in the cytoplasm, the site of synthe- 
sis of the precursor. 
The level of synthesis of precursor could be roughly esti- 
mated by assay of the processed product, the OTC enzyme. 
The amount of OTC enzymatic activity detected in the OD 
cells is comparable to that found in normal liver, the usual 
site of expression; this enzymatic activity is about two orders 
of magnitude greater than that obtained with most OTC-Neo 
co-transformants previously analyzed. From analysis of total 
radiolabeled proteins  from the  OD5  cell  line,  we  estimate 
OTC enzyme to comprise ~0.1% of total soluble protein (data 
not  shown).  This  estimate  agrees well  with  the  figure  for 
normal  liver and also corresponds to the  detected  level of 
enzyme activity. Apparently, expression of OTC in HeLa cells 
at a level similar to that of liver does not saturate the pathway 
of mitochondrial import of these cells, because there was no 
observable accumulation of OTC precursor. It is interesting 
that the amount of DHFR in the cells is estimated at several 
percent of total soluble protein (data not shown). We cannot 
at this time explain why this product should be present at a 
level an order of magnitude greater than OTC. 
Rate of Import of OTC in HeLa Cells 
Accumulation of the OTC precursor could be observed in 
the presence of an inhibitor of import, DNP. Removal of the 
inhibitor permitted subsequent observation of formation of 
mature subunit as a measure of the rate of import. The tl/2 
for import was estimated to be <2 min. Similar determina- 
tions have been carried out for three other mammalian mi- 
tochondrial  precursors,  and  tl/2  values  were  obtained  that 
range from 1 to 10 minutes (13,  18,  19). Differences of these 
measurements may  reflect  experimental  error  and  do  not 
indicate whether different rates and pathways of import are 
followed by different precursors. Experiments involving cold 
chase  in  the  presence  of DNP  indicate  a  half-life  for the 
cytoplasmic OTC precursor of ~30 rain, significantly greater 
than the t~/2 for its import (data not shown).  The high effi- 
ciency of mitochondrial protein transport argues strongly for 
the involvement of receptors, one of which has been demon- 
strated in the outer membrane of the mitochondria of New 
rospora  (20).  The receptors involved must not only rapidly 
bind precursors but must also be able to release them rapidly 
to the subsequent steps in the pathway. Inhibition of Import of OTC in OD5 Cells by the 
Arginine Analogue Canavanine 
The substitution of the amino acid analogue, canavanine, 
for arginine in the medium of OD5 cells had a striking effect 
on  the  forms of precipitable  OTC  detected  in  these  cells. 
When canavanine was added at a concentration of 2 mM a 
form of OTC was detected that is presumed, based on nearly 
identical mobility to the normal product and upon detection 
in the presence of R6G, to be a canavanine-substituted OTC 
precursor.  A  small  fraction of this  product  has apparently 
been imported by mitochondria and proteolytically processed 
because in the presence of 2 mM canavanine a minor product 
was also detected that was intermediate in mobility between 
that of normal precursor and normal mature subunit.  It is 
deafly a  mitochondrial proteolytic product because its for- 
mation is blocked by R6G. It is unclear whether this product 
has been cleaved at a site other than that producing the mature 
subunit,  or  whether  it  is  a  canavanine-substituted  mature 
subunit.  In either case,  most of the canavanine-substituted 
precursor fails to negotiate one or more steps of import and/ 
or processing. 
We have no direct evidence for which step is involved but 
offer several hypotheses.  One  possibility is that  intramito- 
chondrial proteolytic processing cannot be carried out on the 
substituted precursor. The arginine residue nearest the site of 
cleavage of the mature subunit  is at position -7.  Based on 
studies of other proteolytic enzymes, it seems unlikely that 
this residue is directly involved with protease recognition. It 
formally remains possible, however, that altered folding of 
the canavanine-substituted precursor obscures the site of pro- 
teolytic cleavage. The much more likely possibility, in  our 
view, is that the  canavanine-substituted precursor is ineffi- 
ciently recognized by mitochondria, perhaps failing to bind 
to an outer membrane receptor. If  the canavanine-substituted 
precursor can be synthesized in  vitro,  its ability to bind to 
isolated rat liver mitochondria can be compared with binding 
of an unsubstituted OTC precursor. 
At the amino acid level, the major effect of substitution of 
canavanine for arginine is on the charge of the synthesized 
polypeptide. The pka of the canavanine side-chain is 6.6  as 
compared with 9.0  for arginine (2 l), which suggests  that at 
neutral pH, the substituted residues may not exhibit as great 
a  net  positive charge  as  is  carried  at  this  pH by arginine 
residues. Thus, a net loss of positive charge in the substituted 
precursor may explain its failure to be efficiently imported 
and/or processed. Consistent with a role for charged residues, 
import and processing was not affected by analogue substi- 
tution of two charge-neutral residues, methionine and phen- 
ylalanine, present in both the leader and mature portion of 
the OTC precursor. 
Given the prediction that leader sequences carry an overall 
positive charge, we may consider that loss of charge, brought 
about by canavanine substitution of all four arginine residues 
in the  OTC leader,  is responsible for inhibition  of import. 
Recent experiments suggest that the leader itself may carry 
sufficient information to direct mitochondrial import (Hor- 
wich, A. L., manuscript in preparation), supporting the idea 
that it is substitution of leader residues per se that interferes 
with import. However, there are eight arginine residues in the 
mature OTC subunit and we cannot, at this time, exclude the 
possibility that  the  effect of canavanine  results  from their 
substitution. Site-directed mutagenesis studies will permit di- 
rect  evaluation  of the  hypothesis  that  the  positive charge 
conferred by basic residues in the leader sequence is required 
for import and/or proteolytic processing. 
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